Literature DB >> 16233428

Effect of composition on the stability of liposomal irinotecan prepared by a pH gradient method.

Tzung-Han Chou1, Shih-Chang Chen, I-Ming Chu.   

Abstract

Liposomal irinotecan was prepared by pH gradient loading. The parameters that govern this process, including drug loading time, incubation temperature, buffer composition for hydration, and deltapH, were studied. The uptake of irinotecan into liposomal systems in response to the magnitude of the pH gradient was examined. The drug uptake was maximum when the magnitude of deltapH approached 3.7. The effect of the formulation of the liposomes on the stability of the drug delivery system was also studied. Liposomes composed of lipids with a high phase transition temperature, L-alpha-distearoyl-phosphatidyl-choline and hydrogenated soy phosphatidylcholine, were more stable than those composed of lipids with lower phase transition temperatures. Incorporating distearoyl phosphatidylethanolamine-poly (ethylene glycol)2000 into liposomes helped to reduce the size of the liposomes. In addition, the retention of a drug within liposomes was found to be slightly enhanced by including dimyristoylphosphatidylglycerol or dextran sulfate in the liposome formulation.

Entities:  

Year:  2003        PMID: 16233428

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  11 in total

Review 1.  Safety Considerations of Cancer Nanomedicine-A Key Step toward Translation.

Authors:  Xiangsheng Liu; Ivanna Tang; Zev A Wainberg; Huan Meng
Journal:  Small       Date:  2020-05-14       Impact factor: 13.281

2.  Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer.

Authors:  Nilesh A Patankar; Dawn Waterhouse; Dita Strutt; Malathi Anantha; Marcel B Bally
Journal:  Invest New Drugs       Date:  2012-05-22       Impact factor: 3.850

3.  Quantitative structure-property relationship modeling of remote liposome loading of drugs.

Authors:  Ahuva Cern; Alexander Golbraikh; Aleck Sedykh; Alexander Tropsha; Yechezkel Barenholz; Amiram Goldblum
Journal:  J Control Release       Date:  2011-12-01       Impact factor: 9.776

4.  Preparation of irinotecan-loaded folate-targeted liposome for tumor targeting delivery and its antitumor activity.

Authors:  Ziqiang Zhang; Jing Yao
Journal:  AAPS PharmSciTech       Date:  2012-05-26       Impact factor: 3.246

5.  Targeted drug delivery utilizing protein-like molecular architecture.

Authors:  Evonne M Rezler; David R Khan; Janelle Lauer-Fields; Mare Cudic; Diane Baronas-Lowell; Gregg B Fields
Journal:  J Am Chem Soc       Date:  2007-03-31       Impact factor: 15.419

6.  Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer.

Authors:  Xiangsheng Liu; Allen Situ; Yanan Kang; Katie Rose Villabroza; Yupei Liao; Chong Hyun Chang; Timothy Donahue; Andre E Nel; Huan Meng
Journal:  ACS Nano       Date:  2016-02-09       Impact factor: 15.881

7.  Irinotecan and berberine co-delivery liposomes showed improved efficacy and reduced intestinal toxicity compared with Onivyde for pancreatic cancer.

Authors:  Xue Wang; Ying Liu; Wanjia Xu; Lirui Jia; Dongxu Chi; Jiang Yu; Jiamei Wang; Zhonggui He; Xiaohong Liu; Yongjun Wang
Journal:  Drug Deliv Transl Res       Date:  2021-01-15       Impact factor: 4.617

8.  Sphingomyelin Liposomes Containing Porphyrin-phospholipid for Irinotecan Chemophototherapy.

Authors:  Kevin A Carter; Dandan Luo; Aida Razi; Jumin Geng; Shuai Shao; Joaquin Ortega; Jonathan F Lovell
Journal:  Theranostics       Date:  2016-10-01       Impact factor: 11.556

Review 9.  Artificial Lipid Membranes: Past, Present, and Future.

Authors:  Christina G Siontorou; Georgia-Paraskevi Nikoleli; Dimitrios P Nikolelis; Stefanos K Karapetis
Journal:  Membranes (Basel)       Date:  2017-07-26

10.  Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine.

Authors:  Jun Chen; Guo-jun Yan; Rong-rong Hu; Qian-wen Gu; Ming-lei Chen; Wei Gu; Zhi-peng Chen; Bao-chang Cai
Journal:  Int J Nanomedicine       Date:  2012-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.